BMAL2 has been implicated as an oncogenic driver in multiple human cancers, including lung, colorectal, and breast cancer,28 where it can drive tumorigenesis and create an immunosuppressive micro‐environment for advanced tumor growth. This evidence concerns the gene BMAL2 and neoplasm.